Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

544 indexed citations

Abstract

loading...

About

This paper, published in 2006, received 544 indexed citations. Written by Lalitha Shankar, John M. Hoffman, S.L. Bacharach, Michael M. Graham, Joel S. Karp, Adriaan A. Lammertsma, Steven M. Larson, David A. Mankoff, Barry A. Siegel and Annick Van den Abbeele covering the research area of Cancer Research and Radiology, Nuclear Medicine and Imaging. It is primarily cited by scholars working on Radiology, Nuclear Medicine and Imaging (406 citations), Pulmonary and Respiratory Medicine (221 citations) and Oncology (66 citations). Published in PubMed.

In The Last Decade

doi.org/w29408380 →

Countries where authors are citing Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Specialization
Citations

This map shows the geographic impact of Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. more than expected).

Fields of papers citing Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials..

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w29408380.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026